amber: cobolimab monotherapy & in combination with pd-1 inhibitors nivolumab or dostarlimab
Published 2 years ago • 807 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
2:01
first-in-class anti-cd96 monoclonal antibody alone or with dostarlimab for advanced tumors
-
3:53
garnet: dostarlimab, a pd-1 antibody in advanced solid tumors
-
0:46
the benefits of nivolumab and relatlimab in melanoma
-
1:29
blinatumomab in combination with checkpoint inhibitors for all
-
2:00
clinical trial tests nivolumab for patients with rare brain and spine cancers
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
2:12
a phase ii trial: dostarlimab alone for the treatment of dmmr locally advanced rectal cancer
-
2:38
an exciting new combination to treat advanced solid tumors
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
8:03
immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine ...
-
2:11
clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (aml)
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
2:03
integrated genomic correlates of response to pd-1 inhibitor nivolumab in mrcc
-
7:41
nivolumab potentially superior to standard chemo in advanced melanoma
-
1:38
dr. schadendorf on nivolumab/ ipilimumab combination trial in melanoma
-
4:48
neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
-
4:25
sb2115 plus nivo for solid tumors
-
2:12
impact of pd-l1 expression on urothelial carcinoma genomic alteration profile